Skip to main content Skip to main navigation menu Skip to site footer

An overview of overactive bladder



Abstract

Overactive bladder (OAB) is a common multifactorial disease that can cause a burden to the patient. Despite being a symptomatic diagnosis, several urological examinations need to be done to rule out other possible causes. The management of OAB is specific to each individual, from the very first line of behavioral therapy to surgical for an extremely rare case of OAB. This overview will look out for OAB thoroughly from the epidemiological burden, pathophysiology, clinical presentation and diagnosis, and the current treatment of OAB.

Keywords: Overactive Bladder Urinary Incontinence Urodynamics

References

  1. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. International Urogynecology Journal. 2009;21(1):5–26. Available from: http://dx.doi.org/10.1007/s00192-009-0976-9
  2. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU International. 2011;108(7):1132–8. Available from: http://dx.doi.org/10.1111/j.1464-410x.2010.09993.x
  3. Lapitan MC, Chyeon PLH. The Epidemiology of Overactive Bladder among Females in Asia: A Questionnaire Survey. International Urogynecology Journal and Pelvic Floor Dysfunction. 2001;12(4):226–31. Available from: http://dx.doi.org/10.1007/s001920170043
  4. Moorthy P, Lapitan MC, Quek PLC, Lim PHC. Prevalence of overactive bladder in Asian men: an epidemiological survey. BJU International. 2004;93(4):528–31. Available from: http://dx.doi.org/10.1111/j.1464-410x.2003.04682.x
  5. Powell LC, Szabo SM, Walker D, Gooch K. The economic burden of overactive bladder in the United States: A systematic literature review. Neurourology and Urodynamics. 2018;37(4):1241–9. Available from: http://dx.doi.org/10.1002/nau.23477
  6. Bartley JM, Blum ES, Sirls LT, Peters KM. Understanding Clinic Options for Overactive Bladder. Current Urology Reports. 2013;14(6):541–8. Available from: http://dx.doi.org/10.1007/s11934-013-0353-6
  7. Meng E, Lin W-Y, Lee W-C, Chuang Y-C. Pathophysiology of Overactive Bladder. LUTS: Lower Urinary Tract Symptoms. 2012;4:48–55. Available from: http://dx.doi.org/10.1111/j.1757-5672.2011.00122.x
  8. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline. Journal of Urology. 2012;188(6S):2455–63. Available from: http://dx.doi.org/10.1016/j.juro.2012.09.079
  9. Robinson D, Cardozo L. Managing overactive bladder. Climacteric. 2019;22(3):250–6. Available from: http://dx.doi.org/10.1080/13697137.2018.1552254
  10. Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10(10):CD005654–CD005654. Available from: https://pubmed.ncbi.nlm.nih.gov/30288727
  11. White N, Iglesia CB. Overactive Bladder. Obstetrics and Gynecology Clinics of North America. 2016;43(1):59–68. Available from: http://dx.doi.org/10.1016/j.ogc.2015.10.002
  12. Nambiar AK, Bosch R, Cruz F, Lemack GE, Thiruchelvam N, Tubaro A, et al. EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence. European Urology. 2018;73(4):596–609. Available from: http://dx.doi.org/10.1016/j.eururo.2017.12.031
  13. Allison SJ, Gibson W. Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience. Ther Adv Urol. 2018;10(12):411–9. Available from: https://pubmed.ncbi.nlm.nih.gov/30574201
  14. Gong Q-Q, Xu Y-Q, Xu J, Ding X-Y, Guo C. Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder. Front Pharmacol. 2020;10:1618–1618. Available from: https://pubmed.ncbi.nlm.nih.gov/32009968
  15. Bhide AA, Tailor V, Fernando R, Khullar V, Digesu GA. Posterior tibial nerve stimulation for overactive bladder-techniques and efficacy. Int Urogynecol J. 2019/12/18 ed. 2020;31(5):865–70. Available from: https://pubmed.ncbi.nlm.nih.gov/31853597
  16. Tutolo M, Ammirati E, Van der Aa F. What Is New in Neuromodulation for Overactive Bladder? European Urology Focus. 2018;4(1):49–53. Available from: http://dx.doi.org/10.1016/j.euf.2018.04.019
  17. Banakhar MA, Al-Shaiji T, Hassouna M. Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem. Ther Adv Urol. 2012;4(4):179–85. Available from: https://pubmed.ncbi.nlm.nih.gov/22852028
  18. Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6â€months in subjects with mild symptoms of overactive bladder. Neurourology and Urodynamics. 2014;34(3):224–30. Available from: http://dx.doi.org/10.1002/nau.22544

How to Cite

Gunawan, I. P. G. F., Suarjana, I. N., & Wulandari, K. F. (2021). An overview of overactive bladder. Bali Medical Journal, 10(1), 208–210. https://doi.org/10.15562/bmj.v10i1.2266
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
1

Total
5

Share

Search Panel

I Putu Gde Fredy Gunawan
Google Scholar
Pubmed
BMJ Journal

I Nyoman Suarjana
Google Scholar
Pubmed
BMJ Journal

Kadek Frida Wulandari
Google Scholar
Pubmed
BMJ Journal